Literature DB >> 11895072

Cardiac arrhythmia in a newborn infant associated with fluoxetine use during pregnancy.

Gadi Abebe-Campino, Dafna Offer, Bracha Stahl, Paul Merlob.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11895072     DOI： 10.1345/aph.10255

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  5 in total

1.  Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

Authors:  S Rajamani; L L Eckhardt; C R Valdivia; C A Klemens; B M Gillman; C L Anderson; K M Holzem; B P Delisle; B D Anson; J C Makielski; C T January
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

Review 2.  Serotonin reuptake inhibitor-induced perinatal complications.

Authors:  Salvatore Gentile
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 3.  SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the Infant.

Authors:  Hedvig Nordeng; Olav Spigset
Journal:  Drug Saf       Date:  2005-07       Impact factor: 5.606

Review 5.  The safety of newer antidepressants in pregnancy and breastfeeding.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.